Literature DB >> 17508225

The implications of ISAT and ISUIA for the management of cerebral aneurysms during pregnancy.

Laurence A G Marshman1, A Robert Aspoas, Manjit S Rai, Sanjiv J Chawda.   

Abstract

Both the International Subarachnoid Aneurysm Trial (ISAT) and the International Study on Unruptured Intracranial Aneurysms (ISUIA) have been widely extrapolated to influence the management of actual or anticipated aneurysmal subarachnoid hemorrhage (SAH). However, it remains possible that sub-groups exist for which such extrapolation might subsequently prove premature. In this review, we discuss the implications that such extrapolation may potentially have for one such SAH sub-group: the clinically rare scenario of SAH in pregnancy.

Entities:  

Mesh：

Year:  2007        PMID： 17508225     DOI： 10.1007/s10143-007-0074-8

Source DB:  PubMed          Journal:  Neurosurg Rev        ISSN： 0344-5607            Impact factor:   2.800


  39 in total

1.  Outcomes of early endovascular versus surgical treatment of ruptured cerebral aneurysms. A prospective randomized study.

Authors:  T Koivisto; R Vanninen; H Hurskainen; T Saari; J Hernesniemi; M Vapalahti
Journal:  Stroke       Date:  2000-10       Impact factor: 7.914

2.  Rupture of congenital intracranial aneurysm in pregnancy.

Authors:  T A DAANE; R W TANDY
Journal:  Obstet Gynecol       Date:  1960-03       Impact factor: 7.661

3.  International Subarachnoid Aneurysm Trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomised trial.

Authors:  Andrew Molyneux; Richard Kerr; Irene Stratton; Peter Sandercock; Mike Clarke; Julia Shrimpton; Rury Holman
Journal:  Lancet       Date:  2002-10-26       Impact factor: 79.321

Review 4.  Intracranial hemorrhage from aneurysms and arteriovenous malformations during pregnancy and the puerperium.

Authors:  M S Dias; L N Sekhar
Journal:  Neurosurgery       Date:  1990-12       Impact factor: 4.654

5.  The significance of unruptured intracranial saccular aneurysms.

Authors:  D O Wiebers; J P Whisnant; T M Sundt; W M O'Fallon
Journal:  J Neurosurg       Date:  1987-01       Impact factor: 5.115

Review 6.  Aneurysmal subarachnoid haemorrhage in pregnancy.

Authors:  Daniel O Selo-Ojeme; Laurence A G Marshman; Amaju Ikomi; Dale Ojutiku; Robert A Aspoas; Sanjiv J Chawda; Gursharan P S Bawa; Manjit S Rai
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2004-10-15       Impact factor: 2.435

7.  Maternal deaths due to spontaneous subarachnoid hemorrhage.

Authors:  A Barno; D W Freeman
Journal:  Am J Obstet Gynecol       Date:  1976-06-01       Impact factor: 8.661

8.  Endovascular stent placement and magnetic resonance angiography for management of hypertension and renal artery occlusion during pregnancy.

Authors:  T T Le; Z J Haskal; G A Holland; R Townsend
Journal:  Obstet Gynecol       Date:  1995-05       Impact factor: 7.661

Review 9.  Pregnancy-related rupture of arterial aneurysms.

Authors:  J M Barrett; J E Van Hooydonk; F H Boehm
Journal:  Obstet Gynecol Surv       Date:  1982-09       Impact factor: 2.347

10.  Patient and staff dosimetry in neuroradiological procedures.

Authors:  N W Marshall; J Noble; K Faulkner
Journal:  Br J Radiol       Date:  1995-05       Impact factor: 3.039
View more
  4 in total

1.  Radiation exposure during pregnancy.

Authors:  Andreas Raabe; Wolfgang-Ulrich Müller
Journal:  Neurosurg Rev       Date:  2008-02-06       Impact factor: 3.042

Review 2.  Intracranial haemorrhage in pregnancy.

Authors:  Jacob M Fairhall; Marcus A Stoodley
Journal:  Obstet Med       Date:  2009-11-30

3.  Non-contrast 3D time-of-flight magnetic resonance angiography for visualization of intracranial aneurysms in patients with absolute contraindications to CT or MRI contrast.

Authors:  Vijay Yanamadala; Sameer A Sheth; Brian P Walcott; Bradley R Buchbinder; Deidre Buckley; Christopher S Ogilvy
Journal:  J Clin Neurosci       Date:  2013-05-16       Impact factor: 1.961

4.  A heparin-rosuvastatin-loaded P(LLA-CL) nanofiber-covered stent inhibits inflammatory smooth-muscle cell viability to reduce in-stent stenosis and thrombosis.

Authors:  Yingjun Liu; Peixi Liu; Yaying Song; Sichen Li; Yuan Shi; Kai Quan; Guo Yu; Peiliang Li; Qingzhu An; Wei Zhu
Journal:  J Nanobiotechnology       Date:  2021-04-29       Impact factor: 10.435
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.